Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare News Netherlands.
Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Further Confirms the Clinical Potential of...
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and...
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
NAARDEN, the Netherlands and MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
Healthcare Cybersecurity Market Set to Grow by 17.7% CAGR
Healthcare Cybersecurity Market Size Was To Reach USD 19.1 Bn In 2022 And Projected To Reach USD 93.6 Bn by 2032 at a CAGR of 17.7%. NEW YORK, NY, UNITED STATES, January 29, 2025 /EINPresswire.com/ -- The Global Healthcare Cybersecurity Market...
Venture Medical Announces Strategic Partnership with Plasmacure to Bring Cold Plasma Therapy System to the U.S. Market
Proven cold plasma therapy system for chronic wound treatment represents patient-first innovation. MISSOULA, MT, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Venture Medical, LLC, a leading provider of advanced wound care solutions, is proud...
Premier’s statement on the 80th anniversary of the liberation of the Netherlands
CANADA, May 5 - Premier David Eby has issued the following statement marking the 80th anniversary of the liberation of the Netherlands: “On May 5, 1945, occupying German forces in the Netherlands surrendered to the Allies, ending five years under...
Owner: Canadian Government
Premier’s statement on the 80th anniversary of the liberation of the Netherlands
CANADA, May 5 - Premier David Eby has issued the following statement marking the 80th anniversary of the liberation of the Netherlands: “On May 5, 1945, occupying German forces in the Netherlands surrendered to the Allies, ending five years under...
Owner: Canadian Government
Ready to Drink (RTD) Tea Market Set to Hit USD 88,802.7 Million by 2035 Amid Rising Health Consciousness | FMI
The Ready-to-Drink (RTD) tea market is witnessing strong growth, driven by rising health consciousness and increasing demand for convenient, natural beverages NEWARK, DE, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The Ready to Drink...
Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th
Shared data underpins key advanced trials in hepatic encephalopathy, acute-on-chronic liver failure (ACLF) and decompensated cirrhosis Management attending conference LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Yaqrit, a late clinical-stage company...
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
First-quarter 2025 Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as oral late-breaker at EASL...
Medicinal Mushrooms Market Estimated at USD 62.0 Billion in 2032, Growing at a CAGR of 8.7%
Medicinal Mushrooms Market witnessed a valuation of USD 27.5 Bn in 2022 and is anticipated to reach USD 62.0 Bn by 2032, at a CAGR of 8.7% from 2023 to 2032. NEW YORK, NY, UNITED STATES, January 30, 2025 /EINPresswire.com/ -- Report Overview The...
Psychotherapist Explores Connection Between Spirituality and Mental Health in Writings Available on Website
LOS ANGELES, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- May marks Mental Health Awareness Month, a topic near and dear to the late Dr. Pieter Noomen, a psychotherapist who worked in suicide prevention and hospice and served as a...
ONWARD Medical Announces Release of 2024 Annual Report
EINDHOVEN, the Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people...
Vegan Protein Market to Hit USD 40.29 Billion by 2034, Fueled by Rising Health-Conscious Consumers
Vegan Protein Food Market Research Report By Product Type, By Source, By Distribution Channel By End User and By Regional - Forecast to 2034 NEW YORK, NY, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Vegan protein food has transitioned from...
Bellame Expands Global Shipping to 17 Countries and Introduces 7-Day-a-Week Fulfillment to Meet Rising Demand
Bellame Expands Global Shipping to 17 Countries and Introduces 7-Day-a-Week Fulfillment to Meet Rising Demand FORT WORTH, TX, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Bellame, the luxury beauty and wellness brand redefining modern...
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a...
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the...
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
VICTORIA, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed...
Atea Pharmaceuticals to Present New Data Showcasing Potential Best-in-Class Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...
